Filing Flows › Standard Biotools (LAB) › Services and Other Revenue revenue
Standard Biotools (LAB) Services and Other Revenue revenue by quarter
Standard Biotools' Services and Other Revenue revenue was $5.1M in Q3 2026 (third quarter 2026), -10% from Q2 2026. Over the last 6 quarters it ranged from $5.1M (Q3 2026) to $6.4M (Q4 2025).
| Quarter | Services and Other Revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.1M | -10% | -12% |
| Q2 2026 | $5.6M | -2% | -8% |
| Q1 2026 | $5.7M | -11% | — |
| Q4 2025 | $6.4M | +11% | — |
| Q3 2025 | $5.8M | -6% | — |
| Q2 2025 | $6.1M | — | — |
Q3 2026 at a glance
Standard Biotools, Q3 2026: revenue $19.4M (-0.9% year over year), operating margin -102.0%, net earnings $13.5M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Standard Biotools' Services and Other Revenue revenue?
Standard Biotools' Services and Other Revenue revenue was $5.1M in Q3 2026 (third quarter 2026), -10% from Q2 2026.
How has Standard Biotools' Services and Other Revenue revenue changed?
Over the last 6 quarters it ranged from $5.1M (Q3 2026) to $6.4M (Q4 2025).